Sequence Bio inks collaboration with Leo Pharma to identify novel dermatologic drug targets
By, Admin1 min read
Share
Sequence Bio, a Newfoundland and Labrador-based discovery biology company, has entered into a collaboration agreement with Danish dermatology specialists LEO Pharma, for use of Sequence Bio
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
